Dr. Steven C. Katz

Dr. Steven C. Katz, MD, is a widely respected surgical oncologist and physician-scientist specializing in hepatobiliary and pancreatic cancers, with a focus on cancer immunotherapy and translational research. He serves as Chief of Surgical Oncology and Director of the Surgical Oncology Research Laboratory at Boston Medical Center and is a Professor of Surgery at Boston University Chobanian & Avedisian School of Medicine. Dr. Katz earned his medical degree from Boston University School of Medicine and completed his residency in general surgery at Beth Israel Deaconess Medical Center, followed by a fellowship in surgical oncology at the National Cancer Institute. He is board-certified in Surgery and is recognized for his expertise in tumor immunology and innovative clinical trial design.

Dr. Katz’s research has focused on the development of novel immune-based therapies for gastrointestinal cancers, including liver and pancreatic malignancies. His laboratory has advanced understanding of the tumor microenvironment and identified strategies to enhance immune responses against solid tumors. He has led multiple translational and clinical studies investigating adoptive cell transfer, checkpoint inhibition, and cancer vaccines. His work has contributed to the integration of immunotherapy approaches into the treatment paradigm for patients with advanced hepatobiliary and pancreatic cancers. He has published extensively in high-impact journals and is frequently invited to present at national and international oncology meetings.

In addition to his research contributions, Dr. Katz is an accomplished educator and mentor, training surgical residents, fellows, and junior investigators in surgical oncology and immunotherapy research. He is active in professional organizations, including the Society of Surgical Oncology and the American Association for Cancer Research, where he has served on committees advancing clinical research initiatives. Through his dedication to surgical innovation, translational science, and mentorship, Dr. Steven C. Katz continues to advance the field of gastrointestinal surgical oncology and immunotherapy.